BJDX
Bluejay Diagnostics, Inc.
There isn't enough reported data to score BJDX yet.
BJDX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate BJDX's fundamentals.
BJDX PE Valuation
BJDX has no meaningful PE right now: it lost money over the past year.
BJDX Forward outlook
There aren't enough analyst estimates for BJDX to show an outlook.
BJDX Earnings Per Share
BJDX Quarterly Revenue
BJDX's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -797% | N/A |
BJDX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$1.7M | +$1.1M |
| Q3 2024 | -$1.9M | -$732.1K |
| Q2 2024 | -$2.1M | -$444.8K |
| Q1 2024 | -$2.3M | +$942.8K |
| Q4 2023 | -$2.9M | +$317.1K |
| Q3 2023 | -$1.2M | +$852.9K |
| Q2 2023 | -$1.7M | +$103.5K |
| Q1 2023 | -$3.3M | -$1.4M |
BJDX has burned cash in almost every quarter: −$7M over the past year, against −$9M the year before.
BJDX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +126% | +653K shares |
| 1 year | +1253% | +1.1M shares |
BJDX has 1M diluted shares, up 1253% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18,560 |
| Q2 2023 | $1,478 |
| Q1 2023 | $57,601 |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
BJDX Net Leverage
BJDX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BJDX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 14.2 | Oversold |
BJDX's weekly RSI is 35 (neutral) and its Stochastic is 14 (oversold).
BJDX PE vs Healthcare Sector
BJDX has no meaningful PE right now: it lost money over the past year.
BJDX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.85 | 8.8% below |
| 20 week MA | $3.64 | 29% below |
| 50 week MA | $8.02 | 68% below |
| 100 week MA | $23.3 | 89% below |
| 200 week MA | $10,698.4 | 100% below |
BJDX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
BJDX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $586,240.0 | $398,080.0 | -32% |
| 2022 | $398,080.0 | $51,955.2 | -87% |
| 2023 | $51,955.2 | $7,808.0 | -85% |
| 2024 | $7,808.0 | $57.9 | -99% |
| 2025 | $57.9 | $11.2 | -81% |
| 2026 YTD | $11.2 | $2.60 | -77% |
BJDX has finished every year since 2021 lower, and it's down 77% so far in 2026.